Semaglutide
14 Common Questions About Semaglutide Answered
Answers to the questions patients ask most.
Amanda Walrath, APRN, FNP-BCOctober 7, 2024
Have questions about your own care? Book your free consult with Amanda by video, available to adults anywhere in Florida.
Considering semaglutide? Nuvo offers compounded semaglutide in Stuart, FL and by telehealth across Florida, $400 per vial with a free consult.See semaglutide →Semaglutide has become one of the most talked-about medications for weight and diabetes. Here are clear answers to the questions we hear most.
1. What is semaglutide?
A prescription medication that mimics GLP-1, a hormone that helps regulate blood sugar and appetite. It belongs to a class called GLP-1 receptor agonists.
2. How does it work?
It helps your pancreas release insulin when blood sugar rises, lowers glucagon, and slows stomach emptying. Together, these steady blood sugar and reduce appetite. Semaglutide is not insulin, which is a common myth I hear. If you don't have diabetes, you usually don't need to check your blood sugar at home.
3. What is it used for?
Brand-name semaglutide is FDA-approved for type 2 diabetes (Ozempic) and for chronic weight management (Wegovy) in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition.
4. What are the side effects?
Most common are nausea, vomiting, and diarrhea, usually worst in the first weeks. Rare but serious risks include pancreatitis and kidney problems. It carries a boxed warning about thyroid C-cell tumors seen in animal studies.
5. How is it taken?
As a once-weekly injection under the skin of the abdomen, thigh, or arm. At Nuvo, compounded semaglutide comes in a vial with syringes and clear, step-by-step dosing instructions.
6. Who should consider it?
Adults who haven't reached their goals with diet and exercise alone, especially with weight-related conditions. It isn't appropriate for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. If you've been eating well and exercising with nothing changing, you're not alone. I was in the same place before I tried it myself.
7. Can it be used long-term?
Yes, it can be used long-term under medical supervision, with regular check-ins to confirm it remains safe and effective for you.
8. What lifestyle changes help?
A balanced, whole-food diet, adequate protein, and about 150 minutes of moderate activity per week, including strength training.
9. How does it compare to other treatments?
It addresses both blood sugar and appetite, and in clinical trials it produced more weight loss than diet and exercise alone. Your provider can help you compare it with options like tirzepatide.
10. What should I know before starting?
Share your full medical history and current medications with your provider, and learn how to inject, store, and dose your medication.
11. Does it interact with other medications?
Combining it with insulin or sulfonylureas can raise the risk of low blood sugar. Because it slows digestion, it can affect how some oral medications are absorbed. Tell your provider about everything you take.
12. How much does it cost?
Without insurance, brand-name semaglutide is about $349 per month for most doses through the manufacturer's self-pay program as of October 2026, and coverage varies. At Nuvo, compounded semaglutide is $400 per vial, lasting about 12 weeks depending on your dose, with no membership.
13. Where can I get it?
It requires a prescription from a licensed provider. Make sure any pharmacy or online service is licensed, names its pharmacy, and requires a real medical evaluation.
14. What should I expect when starting?
Semaglutide is usually started at a low weekly dose and increased gradually only when your provider directs. Digestive side effects such as nausea or constipation are most common early on or after a dose change. Check in with your provider if anything feels off. Individual results vary.
This article is educational and not medical advice. Compounded medications are not FDA-approved. Individual results vary.
